N-acetylcysteine to ameliorate acute renal injury in a rat cardiopulmonary bypass model

Journal of Thoracic and Cardiovascular Surgery

Volumn 133, Issue 3, 2007, Pages

  Zhu, Jiaquan ^a   Yin, Rong ^a   Shao, Hongtao ^a   Dong, Guohua ^a   Luo, Liguo ^a   Jing, Hua ^a  

^a JINLING HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; CATALASE; CREATININE; CYSTATIN C; GLUTATHIONE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MALONALDEHYDE; SUPEROXIDE DISMUTASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD SAMPLING; CARDIOPULMONARY BYPASS; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DISEASE MODEL; DRUG EFFECT; DRUG EFFICACY; DRUG MEGADOSE; ENZYME ACTIVITY; EPITHELIUM CELL; KIDNEY EPITHELIUM; KIDNEY INJURY; KIDNEY TUBULE NECROSIS; LOW DRUG DOSE; MALE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RAT; SPRAGUE DAWLEY RAT; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 33847047928     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2006.09.046     Document Type: Article

References (31)

1. Chertow G.M., Lazarus J.M., Christiansen C.L., Cook E.F., Hammermeister K.E., Grover F., et al. Preoperative renal risk stratification. Circulation 95 (1997) 878-884
2. Burns K.E., Chu M.W., Novick R.J., Fox S.A., Gallo K., Martin C.M., et al. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing CABG surgery: a randomized controlled trial. JAMA 294 (2005) 342-350
3. Sear J.W. Kidney dysfunction in the postoperative period. Br J Anaesth 95 (2005) 20-32
4. Birck R., Krzossok S., Markowetz F., Schnulle P., van der Woude F.J., and Braun C. Acetylcysteine for prevention of contrast nephropathy: meta-analysis. Lancet 362 (2003) 598-603
5. Bagshaw S.M., McAlister F.A., Manns B.J., and Ghali W.A. Acetylcysteine in the prevention of contrast-induced nephropathy: a case study of the pitfalls in the evolution of evidence. Arch Intern Med 166 (2006) 161-166
6. Erdogan H., Fadillioglu E., Yagmurca M., Ucar M., and Irmak M.K. Protein oxidation and lipid peroxidation after renal ischemia-reperfusion injury: protective effects of erdosteine and N-acetylcysteine. Urol Res 34 (2006) 41-46
7. Esrefoglu M., Gul M., Ates B., Batcioglu K., and Selimoglu M.A. Antioxidative effect of melatonin, ascorbic acid and N-acetylcysteine on caerulein-induced pancreatitis and associated liver injury in rats. World J Gastroenterol 12 (2006) 259-264
8. Ritter C., da Cunha A.A., Echer I.C., Andrades M., Reinke A., Lucchiari N., et al. Effects of N-acetylcysteine plus deferoxamine in lipopolysaccharide-induced acute lung injury in the rat. Crit Care Med 34 (2006) 471-477
9. Aitio M.L. N-acetylcysteine-passe-partout or much ado about nothing?. Br J Clin Pharmacol 61 (2006) 5-15
10. Koramaz I., Pulathan Z., Usta S., Karahan S.C., Alver A., Yaris E., et al. Cardioprotective effect of cold-blood cardioplegia enriched with N-acetylcysteine during coronary artery bypass grafting. Ann Thorac Surg 81 (2006) 613-618
11. Fischer U.M., Tossios P., and Mehlhorn U. Renal protection by radical scavenging in cardiac surgery patients. Curr Med Res Opin 21 (2005) 1161-1164
12. Fischer U.M., Tossios P., Huebner A., Geissler H.J., Bloch W., and Mehlhorn U. Myocardial apoptosis prevention by radical scavenging in patients undergoing cardiac surgery. J Thorac Cardiovasc Surg 128 (2004) 103-108
13. Fischer U.M., Cox Jr. C.S., Allen S.J., Stewart R.H., Mehlhorn U., and Laine G.A. The antioxidant N-acetylcysteine preserves myocardial function and diminishes oxidative stress after cardioplegic arrest. J Thorac Cardiovasc Surg 126 (2003) 1483-1488
14. Eren N., Cakir O., Oruc A., Kaya Z., and Erdinc L. Effects of N-acetylcysteine on pulmonary function in patients undergoing coronary artery bypass surgery with cardiopulmonary bypass. Perfusion 18 6 (2003) 345-350
15. Tossios P., Bloch W., Huebner A., Raji M.R., Dodos F., Klass O., et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 126 (2003) 1513-1520
16. Dong G.H., Xu B., Wang C.T., Qian J.J., Liu H., Huang G., et al. A rat model of cardiopulmonary bypass with excellent survival. J Surg Res 123 (2005) 171-175
17. Modine T., Azzaoui R., Fayad G., Lacroix D., Bordet R., Warembourg H., et al. A recovery model of minimally invasive cardiopulmonary bypass in the rat. Perfusion 21 (2006) 87-92
18. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measurement with the Folin phenol reagent. J Biol Chem 193 (1951) 265-275
19. Sun Y., Oberley L.W., and Li Y. A simple method for clinical assay of superoxide dismutase. Clin Chem 34 (1988) 497-500
20. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of enzymatic analysis (1974), Academic, New York 673-677
21. Ellman G.L. Tissue sulfhydryl groups. Arch Biochem Biophys 82 (1959) 70-77
22. Mihara M., and Uchiyama M. Determination of malonaldehyde precursor in tissues by thiobarbituric acid test. Anal Biochem 86 (1978) 271-278
23. Carroll J.E., Howard E.F., Hess D.C., Wakade C.G., Chen Q., and Cheng C. Nuclear factor-κB activation during cerebral reperfusion: effect of attenuation with N-acetylcysteine treatment. Brain Res Mol Brain Res 56 (1998) 186-191
24. Angdin M., Settergren G., Starkopf J., Zilmer M., Zilmer K., and Vaage J. Protective effect of antioxidants on pulmonary endothelial function after cardiopulmonary bypass. J Cardiothorac Vasc Anesth 17 3 (2003) 314-320
25. Filler G., Bokenkamp A., Hofmann W., Le Bricon T., Martinez-Bru C., and Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 38 (2005) 1-8
26. Abu-Omar Y., Mussa S., Naik M.J., MacCarthy N., Standing S., and Taggart D.P. Evaluation of Cystatin C as a marker of renal injury following on-pump and off-pump coronary surgery. Eur J Cardiothorac Surg 27 (2005) 893-898
27. Herget-Rosenthal S., Marggraf G., Husing J., Goring F., Pietruck F., Janssen O., et al. Early detection of acute renal failure by serum cystatin. Kidney Int 66 (2004) 1115-1122
28. Hoffmann U., Fischereder M., Kruger B., Drobnik W., and Kramer B.K. The value of N-acetylcysteine in the prevention of radiocontrast agent-induced nephropathy seems questionable. J Am Soc Nephrol 15 (2004) 407-410
29. Lameire N., Van Biesen W., and Vanholder R. Acute renal failure. Lancet 365 (2005) 417-430
30. Rangan G.K., Wang Y., Tay Y.C., and Harris D.C. Inhibition of NFκB activation with antioxidants is correlated with reduced cytokine transcription in PTC. Am J Physiol 277 5 Pt 2 (1999) F779-F789
31. Lessio C., de Assuncao Silva F., Gloria M.A., Di Tommaso A.B., Gori Mouro M., Di Marco G.S., et al. Cyclosporine A and NAC on the inducible nitric oxide synthase expression and nitric oxide synthesis in rat renal artery cultured cells. Kidney Int 68 (2005) 2508-2516